Cancer Antigen CA19-9 Antibody |
|||
abx020534-1mg | Abbexa | 1 mg | EUR 718.8 |
Cancer Antigen CA19-9 Antibody |
|||
abx020535-1mg | Abbexa | 1 mg | EUR 718.8 |
Cancer Antigen CA 19-9 Antibody |
|||
abx023798-1mg | Abbexa | 1 mg | EUR 1053.6 |
Liver cancer antibody screening array |
|||
LV1001 | TissueArray | each | EUR 306 |
Description: Liver cancer antibody screening array, including TNM, clinical stage and pathology grade, 25 cases/100 cores |
Urinary Bladder Cancer Antigen (UBC) Antibody |
|||
abx239152-100ug | Abbexa | 100 ug | EUR 610.8 |
Cancer Susceptibility 3 (CASC3) Antibody |
|||
abx235220-100ug | Abbexa | 100 ug | EUR 577.2 |
Cancer Susceptibility 3 (CASC3) Antibody |
|||
20-abx213746 | Abbexa |
|
|
Cancer Susceptibility 3 (CASC3) Antibody |
|||
20-abx214020 | Abbexa |
|
|
Cancer Susceptibility 3 (CASC3) Antibody |
|||
20-abx111351 | Abbexa |
|
|
Cancer Susceptibility 3 (CASC3) Antibody |
|||
abx025070-400ul | Abbexa | 400 ul | EUR 627.6 |